NACL Industries Posts Standalone Profit Surge, But Consolidated Shows Losses

CHEMICALS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
NACL Industries Posts Standalone Profit Surge, But Consolidated Shows Losses
Overview

NACL Industries announced stellar standalone Q3 FY26 results with net profit soaring 421% to ₹2,350 lakhs and EPS at ₹1.08. However, consolidated figures painted a different picture, with net profit a mere ₹533 lakhs and a negative basic EPS of (₹1.68) due to flat Q3 revenue. The company also approved a new fair disclosure policy, subsidiary funding, and noted a minor BSE fine.

📉 The Financial Deep Dive

NACL Industries Limited presented a stark dichotomy in its unaudited financial results for the quarter and nine months ended December 31, 2025. While standalone performance surged, consolidated figures showed significant weakness.

The Numbers:

  • Standalone Q3 FY26 Performance:
    • Revenue from operations reached ₹29,018 lakhs, marking an 8.8% year-on-year (YoY) increase from ₹26,652 lakhs in Q3 FY25.
    • Net Profit after tax witnessed a dramatic 421% jump to ₹2,350 lakhs, significantly higher than ₹451 lakhs in the prior year quarter.
    • Basic Earnings Per Share (EPS) consequently rose by 86% YoY to ₹1.08 from ₹0.58.
  • Standalone 9M FY26 Performance:
    • Revenue from operations grew 12% YoY to ₹1,17,502 lakhs.
  • Consolidated Q3 FY26 Performance:
    • Revenue from operations remained flat at ₹26,777 lakhs YoY.
    • Net Profit after tax saw a marginal 1.3% increase to ₹533 lakhs from ₹526 lakhs in Q3 FY25.
    • Crucially, Basic EPS turned negative, recorded at (₹1.68) compared to ₹0.25 in the previous year, indicating an overall loss at the consolidated level for the quarter.
  • Consolidated 9M FY26 Performance:
    • Revenue from operations showed a healthy 18% YoY growth to ₹1,22,351 lakhs.

The Quality:

The substantial divergence between standalone and consolidated results is the most critical aspect. The standalone net profit surge suggests strong operational performance at the parent company level. However, the flat consolidated revenue and negative EPS in Q3 FY26 point towards significant underperformance or drag from subsidiaries, which offset the parent's gains. Specific details on balance sheet items, cash flows, and detailed margin analysis were not provided in the filing.

Key Events:

The Board approved a new fair disclosure policy, a crucial governance step. Funding for wholly-owned subsidiary NACL Spec-Chem Limited was adjusted, with loan tenures extended and interest rates revised downwards to 7.5% from 10% on ₹55 Crores, alongside an approved investment of ₹20 Crores via Compulsorily Convertible Debentures (CCDs). The company also noted a minor BSE fine of ₹55,000 for delayed submission of related party transaction details. A rights issue of ₹24,929 lakhs was allotted on December 31, 2025, primarily for debt repayment and general corporate purposes.

Risks & Outlook:

The primary risk for investors lies in understanding the reasons behind the consolidated underperformance, especially the negative EPS, which contradicts the strong standalone performance. The lack of specific forward-looking guidance from management leaves the outlook uncertain. The recent completion of the rights issue and Coromandel International becoming the promoter are significant structural changes that warrant investor attention.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.